The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

The FDA approval of Diovan HCT and Exforge for first-line use reinforces current US guideline recommendations to start appropriate patients on combination therapy. Research suggests that up to 80% ...

Discover comprehensive details about Amlodipine, Valsartan and Hydrochlorothiazide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it ...

NEW YORK (CNNMoney.com) -- Swiss drugmaker Novartis said Thursday that Exforge, a combination drug for treating high blood pressure that includes one of its top-selling blockbusters, has been ...

The US Food and Drug Administration has approved the two single-pill combos – Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide) and Exforge (amlodipine and valsartan) – as initial therapies in ...

Teva Pharmaceutical Industries Limited ( TEVA) has launched its generic version of Novartis' ( NVS) Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the U.S. Exforge HCT is ...